Viral suppression and HIV drug resistance at 6 months among women in Malawi's Option B+ program: Results from the PURE Malawi Study

BACKGROUND: In 2011, Malawi launched Option B+, a program of universal ART treatment for pregnant and lactating women to optimize maternal health and prevent pediatric HIV infection. For optimal outcomes, women need to achieve HIVRNA suppression. We report 6 month HIVRNA suppression and HIV drug res...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Acquir Immune Defic Syndr
Autori principali: Hosseinipour, Mina, Nelson, Julie AE, Trapence, Clement, Rutstein, Sarah E., Kasende, Florence, Kayoyo, Virginia, Kaunda-Khangamwa, Blessings, Compliment, Kara, Stanley, Christopher, Cataldo, Fabian, van Lettow, Monique, Rosenberg, Nora E., Tweya, Hannock, Gugsa, Salem, Sampathkumar, Veena, Schouten, Erik, Eliya, Michael, Chimbwandira, Frank, Chiwaula, Levison, Kapito-Tembo, Atupele, Phiri, Sam
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5431274/
https://ncbi.nlm.nih.gov/pubmed/28498184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000001368
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi